Stocksigma LogoStocksigma Logo

Dr. Lal PathLabs Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Million)

■ Revenue: 8,739 (+19.6% YoY | +9.6% QoQ) ■ EBITDA: 2,801 (+25.0% YoY | +13.2% QoQ) ■ EBITDA Margin (%): 32.1 (+138 bps YoY | +103 bps QoQ) ■ PAT: 1,922

Dr. Lal PathLabs Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Million)

Dr. Lal PathLabs Ltd · Outcome · 04 Nov 2026, 6:57 pm

Dr. Lal PathLabs Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Million) ■ Revenue: 8,739 (+19.6% YoY | +9.6% QoQ) ■ EBITDA: 2,801 (+25.0% YoY | +13.2% QoQ) ■ EBITDA Margin (%): 32.1 (+138 bps YoY | +103 bps QoQ) ■ PAT: 1,922 (+27.6% YoY | +13.4% QoQ) ■ EPS (INR): 11.5 (+27.3% YoY | +13.2% QoQ)

Original exchange filing (PDF)

More announcements from Dr. Lal PathLabs Ltd

  • Attached · 11 Nov 2026
  • Attached · 10 Nov 2026
  • Attached · 05 Nov 2026
  • Attached · 04 Nov 2026
  • Attached · 04 Nov 2026
  • Attached · 04 Nov 2026
  • Dr. Lal Path Labs Ltd. has informed the Exchange regarding Appointment of Ms Vasuta Agarwal as Additional Director designated as Non- Executive Independent Director of the company w.e.f. November 04, 2026. · 04 Nov 2026
  • Attached · 04 Nov 2026

All Dr. Lal PathLabs Ltd announcements